AbbVie Inc.
Close on Nov 3, 2026Market cap $505.40BP/E 80.8Yield 2.33%
AbbVie Restructuring Charges [legacy through FY20Q1] by Year
Restructuring Charges [legacy through FY20Q1] ($M) ($M)
AbbVie Restructuring Charges [legacy through FY20Q1]: $219M in FY2019, up 271.2% from a year earlier. No newer figure appears in the documents we track.
Where the FY2019 figure comes from
Source: Form 10-K (filed 2020-02-21) ↗
Reported in Form 10-Q / 10-K Restructuring Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring Charges [legacy through FY20Q1] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2019 | Dec 31, 2019 | 219 | +271.2% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 59 | -31.4% | Form 10-K (filed 2020-02-21) ↗ |
| FY2017 | Dec 31, 2017 | 86 | +65.4% | Form 10-K (filed 2020-02-21) ↗ |
| FY2016 | Dec 31, 2016 | 52 | -58.7% | Form 10-K (filed 2019-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 126 | – | Form 10-K (filed 2018-02-16) ↗ |
Breakdown
What makes up restructuring Charges [legacy through FY20Q1]
Cite this data
StockData. (2026). AbbVie Restructuring Charges [legacy through FY20Q1] ($M), annual FY2015–FY2019 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/restruct-exp-leg
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.
See a number that looks wrong?